ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K Activation
Elisenda Alsina‐Sanchís(Institut d'Investigació Biomédica de Bellvitge), Francesc Viñals(Bellvitge University Hospital), Luisa M. Botella(Centro de Investigaciones Biológicas Margarita Salas), Carla Riera‐Domingo(VIB-KU Leuven Center for Cancer Biology), Oriol Casanovas(Institut Català d'Oncologia), Yaiza García-Ibáñez(Institut d'Investigació Biomédica de Bellvitge), Xavier Matías‐Guiu(Universitat de Lleida), Ana M. Figueiredo(University of Lisbon), Mariona Graupera(Josep Carreras Leukaemia Research Institute), Antoni Riera-Mestre(Bellvitge University Hospital), Miguel Ángel Pujana(Bellvitge University Hospital)
Cited by 104
Related Papers
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
|Cancer Cell|2009|2.3k
Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors
|Cancer Cell|2005|1.6k
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k
<scp>FIGO</scp> staging of endometrial cancer: 2023
|International Journal of Gynecology & Obstetrics|2023|926
Network modeling links breast cancer susceptibility and centrosome dysfunction
|Nature Genetics|2007|634